Vinay Prasad

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Vinay Prasad
Aug 29, 2024, 16:53 | Insight
Dario Trapani: Very informative story on how clinical trials have been so far "tolerated" in their design
Dario Trapani shared a post on X about a paper by Vinay Prasad et al.…
Jul 24, 2024, 01:01 | Blog
Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared his previous post on X,…
Jul 22, 2024, 12:29 | Insight
Vinay Prasad: How often does fertility preservation help prior to chemotherapy
Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post on LinkedIn about…
Jul 18, 2024, 15:06 | Opinion
Vinay Prasad: When the patient is in the room, stop typing your note
Mark Lewis shared a post by Vinay Prasad, Professor of Epidemiology and Biostatistics at the University…
Jul 13, 2024, 15:19 | Blog
Kristina Jenei: Are countries harmonizing up or down?
Dario Trapani, Medical Oncologist at European Institute of Oncology, shared a post by Kristina Jenei, Associate…
Jul 5, 2024, 06:31 | Blog
Timothée Olivier: CDK4/6 inhibitors as adjuvant therapy in ER+ /HER2- early breast cancer
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X: "Our…
Jun 29, 2024, 04:26 | Blog
The THEOREMM Project by Timothée Olivier and team
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared…
Jun 24, 2024, 01:26 | Blog
Timothée Olivier: Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
Jun 23, 2024, 11:08 | Drugs
Vinay Prasad: We look at all Adjuvant and Neoadjuvant drugs approved by FDA in last 5 years
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
Jun 22, 2024, 12:13 | Blog
Ade Adamson: Nice write up by Timothée Olivier and Vinay Prasad on our melanoma overdiagnosis paper
Timothée Olivier shared a post by Ade Adamson, Assistant professor in the Department of Internal Medicine…
Jun 19, 2024, 08:32 | Blog
Timothée Olivier: Vinay Prasad and I discussed top abstracts of ASCO24
Timothée Olivier recently shared a post on X: "Post ASCO! Vinay Prasad and I discussed…
Jun 6, 2024, 10:53 | Insight
Earle Burgess: The best part of the oral prostate cancer session at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “What…
May 28, 2024, 14:05 | Blog
Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 25, 2024, 10:05 | Insight
Marco Donia: The Role of PD-L1 Assessment in Dual Checkpoint Inhibition for Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "The…
May 24, 2024, 14:53 | Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 22, 2024, 04:25 | Blog
Timothée Olivier: One of the most important and practice-changing piece this year
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X…
May 13, 2024, 14:54 | Blog
Luca De Fiore: Forward's annual meeting is approaching
Luca De Fiore, managing director of Il Pensiero Scientifico Editore scientific publishing company, shared on X/Twitter:…
May 5, 2024, 07:48 | Blog
Timothée Olivier: The regulatory failure of sotorasib in lung!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…
Apr 30, 2024, 11:54 | Societies
15 Posts Not To Miss from APCCC24!
The Advanced Prostate Cancer Consensus Conference 2024 (APCCC24) was held from April 25th to April…
Apr 5, 2024, 18:16 | Insight
Timothée Olivier: NATALEE trial, adjuvant ribociclib 21 days/28 for… 3 years! Cost alert!!
Timothée Olivier, Medical Oncologist at HUG - Geneva University Hospitals, shared a post by the…
Mar 5, 2024, 01:35 | Insight
Timothée Olivier: Final results of ASCENT in patients with TNBC…
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by Markus…
Mar 5, 2024, 01:20 | Blog
Vinay Prasad: A scoping review of all 2:1, 3:1, etc randomization ratios
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
Feb 24, 2024, 11:26 | Insight
Timothée Olivier: One of my favorite paper with Vinay
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by…
Feb 22, 2024, 18:51 | Positive
Aaron Goodman: 2 of my mentors have the most important attribute in a mentor, the ability to make you think differently
Aaron Goodman shared a post on X/Twitter: "What Is a Mentor? | NEJM 2 of my…
Feb 22, 2024, 18:26 | Blog
Vinay Prasad: This work of fiction actually used experiments to advance understanding of the world. Most books teach dogma My full book review will come soon
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared…
Feb 5, 2024, 11:23 | Insight
Vinay Prasad: We estimate how many people are eligible for CAR-T
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 18, 2024, 15:43 | Blog
Vinay Prasad: A balanced perspective on a new safety alert
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Jan 4, 2024, 16:59 | Insight
Vinay Prasad: When do the checkpoint inhibitors work
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 29, 2023, 16:10 | Blog
Amalia Aleck: 'Someone has been giving our smoldering MM patients MDS and AML! Let’s GOOOOOOOO!'
Amalia Aleck, Anesthesiologist at Valley Anesthesiology Consultants, tweeted on X/Twitter: "Everyone: it’s a good time of…
Dec 29, 2023, 11:29 | Opinion
Vinay Prasad: How to read a science paper
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 27, 2023, 13:40 | Blog
Vinay Prasad: An evidence based embarrassment
Vibay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 27, 2023, 08:59 | Insight
Jonas Nilsson: Interesting and balanced discussion on a recent safety signal of CAR-T cells in plasma cell disorders
Jonas Nilsson Chair of Melanoma Discovery at The University of Western Australia and Harry Perkins…
Dec 22, 2023, 18:19 | Insight
Vinay Prasad: How to actually reduce burnout
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 20, 2023, 10:50 | Blog
Vinay Prasad: About a wild drug approval
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 11, 2023, 18:18 | Blog
Vinay Prasad: This is a great metaphor for the role of professional societies in driving progress
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 5, 2023, 12:33 | Blog
Puneet Bhargava: If you are MID-CAREER this tweet is for you
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Dec 1, 2023, 22:43 | Opinion
Vinay Prasad: Most big data papers are awful
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Nov 26, 2023, 17:07 | Blog
Vinay Prasad: My book review of "The Goldfinch" by Donna Tartt
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Nov 23, 2023, 02:53 | Blog
Vinay Prasad: Benefits of having a grad student
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Nov 9, 2023, 12:21 | Blog
Vinay Prasad: About what happened before and after this photo was taken nearly 20 years ago
Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California…
Nov 6, 2023, 18:17 | Blog
Vinay Prasad: What every trainee needs to know about observational studies
Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post on…
Oct 28, 2023, 16:36 | Insight
Vinay Prasad: The most interesting thing you'll read about PFS, EFS, DFS in oncology this year
Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post by…
Oct 18, 2023, 19:07 | Insight
SANO trial: What do patients with esophagus cancer value?
Krishan Jethw, Nina Niu Sanford and Vinay Prasad shared some insights on the SANO trial on…
Oct 10, 2023, 16:14 | Blog
Kristina Jenei: Nurses are key in advocating for patients.
Kristina Jenei, Public Health Researcher at the University of British Columbia, shared a post by…
Oct 9, 2023, 18:57 | Blog
Marco Donia: All (almost) you need to know about Evidence in Cancer Immunotherapy.
Marco Donia, Clinical Research Associate Professor at University of Copenhagen, shared a post on LinkedIn,…
Aug 16, 2023, 18:14 | Blog
Kevin Neilson: I was photographing Dr. Vinay Prasad. Be sure to capture his heroic visage.
In a LinkedIn post, Kevin Neilson, writer and photographer, states: ''When I told family and…
Jul 29, 2023, 18:18 | Opinion
Every oncology fellow should be handed a copy of this on day 1 - Aaron Goodman
Every oncology fellow should be handed a copy of this on day 1. (many current…
Jul 24, 2023, 18:23 | Drugs
These drugs are $$$! i.e. avapritinib = $44,000/bottle - Michael Lam
Patients on oral chemo after dose reduction: "I still have these pills at home, but…
Jul 6, 2023, 05:11 | Insight
Even weak evidence 3 drugs better than 2 - Vinay Prasad
New paper this week walks through the RCT landscape in myeloma and shows poor post-protocol…
All: 49 Posts: 1 - 100
Special Coverage